A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD patients. Supportive Measures Device Factors Octreotide Desmopressin Anti-secretory Agents (H2RA, PPI) Secondary Prevention: RAAS blockade Thalidomide Danazol Anticoagulation #LVAD #Bleeding #Pharmacology #Management #Treatment #Medications #Secondary #Prevention
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief π΅π πΊπΈ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/